FDA — Fidia SpA Share News
0.000.00%
Last trade - 00:00- €15.49m
- €19.02m
- €30.53m
Brief: Fidia Identifies Potential Partners For Restructuring Deal
Brief: Fidia Says Court Of Ivrea Extends Deadline To File Request For Creditors' Protection Agreement
Brief: Fidia To File Request To Postpone Final Proposal Of Creditors' Protection Agreement
Brief: Fidia Says Court Of Ivrea Extends Period Of Creditor Protection Agreeement
Brief: Fidia Files Extension For Final Proposal Of Creditor Protection Agreeement
Meridian Bioscience: Falls after FDA seeks additional data on COVID-19 test
Spero Therapeutics: Falls after FDA puts clinical hold on antimicrobial therapy study
Brief: Court In Ivrea Admits Fidia To Creditor Protection Agreement
Brief: Italy's Bourse says shares in Fidia temporarily suspended pending statement
Brief: Fidia H1 Net Loss Narrows To EUR 3.1 Mln
Brief: Fidia Issues Business Plan 2020-2024
Brief: Fidia Signs Agreement With Trade Unions On Closing Of Plant In San Secondo Di Pinerolo
Brief: Fidia Q1 EBITDA Loss Shrinks To EUR 1.3 Mln
Brief: Fidia SpA Issues Statement On Finalization Of A Standstill Agreement
Brief: Fidia FY Net Loss Widens To EUR 4.1 Mln
Brief: Fidia Signs Deal With Trade Unions On Solidarity Contract For Forlì Unit
Brief: Fidia USA Says Introduces In U.S. 3-Injection Regimen Triluron
Brief: Fidia Appoints Antonio Breggia Bicchiere CFO
Brief: Fidia Q3 Net Loss Widens To EUR 4.7 Mln